# NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE
> **ANDA076518** · Abbreviated New Drug Application (Generic) · Sponsor: PERRIGO · Approved 2004-03-17
## Drug
- **FDA Application Number:** ANDA076518
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE
- **Generic name:** NAPROXEN SODIUM, PSEUDOEPHEDRINE HCL
- **Active ingredients:** NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** PERRIGO
- **Manufacturer:** Meijer Distribution Inc
- **First approval:** 2004-03-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076518)
---
*AI Analytics · CC0 1.0*